Clinical Trial Update: Convalescent Plasma for Patients With COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 trial update on convalescent plasma for COVID-19 patients, with completed status and results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection

Drugs mentioned

• Convalescent Plasma (convalescent plasma)

Snippet

Sponsor: Henry Ford Health System | Conditions: Coronavirus Infection, Coronavirus | Phase 2 | Status: COMPLETED | Results posted: 2022-05-02